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Background:Krabbe disease is a fatal neurodegenerative disease caused by rapid demyelination of the central and
peripheral nervous systems. The only available treatment, unrelated umbilical cord blood transplantation, is ef-
fective only if performed before clinical symptoms appear. Phenotypic expressions of disease-causing mutations
vary widely, but genotype–phenotype relationships are unclear. Therefore, we evaluated diffusion tensor
imaging (DTI) tractographywith volumetric analysis as a biomarker of earlywhitematter changes and functional
disability in presymptomatic infants.
Methods: We obtained DTI and structural scans of newborns with early-infantile Krabbe disease (n = 9)
diagnosed by family history or newborn screening. We compared white matter ﬁber tract properties to those
of normal controls (n= 336) and assessed the ability of tract-based properties to predict longitudinal develop-
ment in four functional domains (cognitive,ﬁnemotor, grossmotor, adaptive behavior) after treatmentwith un-
related umbilical cord blood transplantation.We also assessed the relationship between the standard evaluation
(modiﬁed Loes score) and DTI results, and the volumetric differences between the Krabbe subjects and normal
controls.
Findings: Reductions in fractional anisotropy were signiﬁcant in the corticospinal tract in the Krabbe patients
compared to controls, which strongly correlatedwithmotor and cognitive outcomes after transplantation. Signif-
icant regional differences were observed in the splenium and uncinate fasciculus in Krabbe patients and these
differences correlated only with cognitive outcomes. Regional brain volumes of Krabbe patients were slightly
larger than controls. Loes scores did not correlate with DTI results.
Interpretation: Neonatal microstructural abnormalities correlate with neurodevelopmental treatment outcomes
in patients treated for infantile Krabbe disease. DTI with quantitative tractography is an excellent biomarker
for evaluating infants with Krabbe disease identiﬁed through newborn screening.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Krabbe disease (globoid cell leukodystrophy) is a rare autosomal re-
cessive disorder caused by a deﬁciency of the lysosomal enzyme
galactocerebrosidase (GALC), which is essential for normal catabolism of
the principal lipid component of myelin. Galactolipid accumulation trig-
gers a pathogenic defect in myelinating glial cells that causes inﬂamma-
tion and rapid demyelination, resulting in progressive deterioration of
the central and peripheral nervous systems (Wenger et al., 2001). This
is a very rare disorder with an incidence of 1 in 70–100,000 live births.
In most patients with Krabbe disease, rapidly progressive demyelination
begins before 6 months of age (early-infantile onset). Symptoms include
irritability, seizures, muscle spasticity, mental deterioration, blindness,. This is an open access article underand deafness. Death usually occurs before 2 years of age (Wenger et al.,
2001). The phenotypic expressions of disease-causing mutations vary,
and in some cases Krabbe disease presents as the late-infantile, juvenile,
or adult onset forms. However, affected siblings follow the same disease
course.
Diagnosis of Krabbe disease is based on family history, genetic test-
ing and clinical symptoms. In addition, a test for GALC enzyme activity
has been developed to screen newborns. In 2006 New York was the
ﬁrst state to include Krabbe disease in its newborn screening program,
with more states to follow (Duffner et al., 2009). Screening involves a
serologic test for the missing GALC enzyme followed by mutational
analysis to conﬁrm the diagnosis. However, neither genotype nor
GALC activity can reliably distinguish the early-infantile form of the dis-
ease from the juvenile and adult forms. Furthermore, some individuals
with low levels of GALC activity may never develop clinical symptoms
(Wenger et al., 2000).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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treatment for early infantile Krabbe disease and is effective only if
performed before symptoms develop (Escolar et al., 2005). Outcomes
of patients who undergo transplantation are signiﬁcantly better than
those of untreated children. Among patients with early-onset Krabbe
disease, those treated as presymptomatic infants shownormal cognitive
function; however, they develop progressive motor disability, growth
failure, and speech difﬁculties (Escolar et al., 2005). Lower survival
rates and more severe disability have been observed in infants with
early-onset disease who underwent transplantation in later stages of
the disease, demonstrating that treatment within the ﬁrst few weeks
of life is critical (Escolar et al., 2005).
Infants currently identiﬁed by newborn screening may develop
early-onset disease, remain healthy, or have late-onset disease, which
is clinically silent until late childhood or even adulthood. An objec-
tive measure of disease progression is urgently needed to determine
whether an asymptomatic baby will develop early-infantile disease
requiring immediate treatment. Once clinical symptoms appear, it
is too late to derive beneﬁts from treatment. As previously reported,
conventional MR images and neurophysiologic tools cannot predict
outcome, and results do not correlate with disease stage, because
these tools are not standardized for use in the neonatal period
(Escolar et al., 2006).
Because transplantation is effective only in the presymptomatic
stages of the disease, it is important to identify a biomarker that can de-
tect changes in the brain before clinical symptoms develop, help deter-
mine the optimal time of treatment, and predict disease onset and
expected phenotype. This information is crucial to clinicians counseling
parents about the treatment of a neonate who screens positive for
Krabbe disease. The purpose of this research is to test whether DTI
with tractography can be used as such biomarker.
DTI is an MRI technique that measures the effective diffusion of
water molecules in biological tissues. DTI provides insight into white
matter development (myelination), reﬂecting changes in axonal ﬁber
size, density, tract coherence, as well as membrane structure and per-
meability (Provenzale et al., 2007; Hermoye et al., 2006; Mukherjee
et al., 2001). The diffusion information within each voxel is synthesized
in the form of a diffusion tensor. By assembling these tensors into tracts
using tractography methods, white matter ﬁber tracts are deﬁned and
grouped into DTI-derived ﬁber bundles based on anatomical knowl-
edge. Because direct interpretation of the 3D image data of diffusion
tensors (represented by 3 × 3 matrix at each voxel) is difﬁcult, simpler
scalar parameters are commonly used for analysis and comparisons.
The trace of the tensor, a measure of the magnitude of diffusion, is
rotationally invariant and referred to as mean diffusivity (MD). The
mostwidely used invariantmeasure of anisotropy, fractional anisotropy
(FA), is quite sensitive to a broad spectrum of pathological conditions.
Parameters like axial diffusivity (AD) and radial diffusivity (RD)
are related to the eigenvalue or a combination of eigenvalues of
the diffusion tensor matrix and have demonstrated more speciﬁc re-
lationships to white matter pathology. RD appears to be modulated
by myelin in white matter and has been shown to be more speciﬁc
for demyelination (Song et al., 2002), whereas AD is more speciﬁc
to axonal degeneration. Consequently all four DTI parameters are
considered along the various ﬁber bundles to provide insight into
tissue microstructure and architectural organization in different re-
gions of the brain.
FA measurements have been shown to be abnormal in early-
infantile Krabbe disease (McGraw et al., 2005). The FA difference in
the corticospinal tracts of presymptomatic newborns with Krabbe
when compared with normal controls is an indicator of early neurolog-
ical changes (Escolar et al., 2009). Therefore, this techniquemay be use-
ful to determine which infants identiﬁed through screening have the
early-infantile form of the disease, requiring immediate treatment. In
addition, pretreatment FA changes may predict gross motor function
after transplantation (Escolar et al., 2009).2. Subjects and methods
2.1. Subjects
Newborns with early-infantile Krabbe disease identiﬁed by family
history or newborn screening were referred to the Program for the
Study of Neurodevelopment in Rare Disorders (NDRD) for assessment
of baseline neurological function before undergoing unrelated umbilical
cord blood transplantation. Patientswere scanned in theﬁrst 6weeks of
life (range 20–49 days). The controls age ranged from 0 to 120 days and
were scanned with the same protocol.
2.2. Brain MRI
Neonates with Krabbe disease referred for transpant evaluations
were scanned using a structural and DTI protocol. We analyzed the
four DTI parameters along six early myelinating white matter ﬁber
tracts – corticospinal (left and right), corpus callosum (genu and
splenium), and uncinate fasciculus (left and right) – for nine neonates
with early-infantile Krabbediseasewho subsequently underwent trans-
plantation. We compared these DTI values with those of 336 age- and
gender-matched controls. To study whether the DTI parameters can
predict long-term outcomes in Krabbe, we evaluated relationships be-
tween DTI parameters with functional development at each patient3s
last evaluation. We tested whether effects we previously reported in
gross motor function, were also present in other domains of function
(cognitive, ﬁnemotor, and adaptive behavior). To explore the hypothe-
sis that in neonatal Krabbe,microstructural differencesmay precede the
development of volumetric differences, we compared volumes of white
matter, gray matter, and cerebrospinal ﬂuid in 27 non-overlapping
regions including the lateral ventricles and tested for structural differ-
ences between Krabbe and controls. To evaluate the strength and sensi-
tivity of the DTI measurements against visual assessment of the MR
images (current practice), we evaluated the relationship betweenmod-
iﬁed Loes score (Provenzale et al., 2009; Loes 1999) and DTI.
2.3. Scanning protocol details
Neonatal controls were recruited as part of a separate study and
were scanned using an identical protocol. All neonates (control and
Krabbe subjects)were scannedwithout sedation at the UNC Biomedical
Research Imaging Center and the Presbyterian Center at the Children3s
Hospital of Pittsburgh either on a Siemens Allegra 3T head-only (UNC)
or a Siemens Tim Trio 3T full-body MR scanner (UNC, Pittsburgh). The
scan protocol consisted of four main imaging sequences— amagnetiza-
tion prepared rapid gradient echo (MP-RAGE) T1-weighted (TR =
1820ms, TI=1100ms, TE=3.75ms, ﬂip angle=7°, 1 × 1× 1mmres-
olution), a T2-weighted sequence, a resting-state functional MRI BOLD
sequence and a single shot echo planar (EPI) DTI sequence (42 direc-
tions). Compatibility of the different scan protocols and across the two
scanners was successfully evaluated with respect to both volumetric
and DTI analyses based on 8 pediatric control subjects scanned on
both scanners. This study was approved by the institutional review
boards at the University of North Carolina and Children3s Hospital of
Pittsburgh. Written informed consent was obtained from the parents
of the infants.
2.4. DTI processing
The processing protocol consisted of multiple repeated diffusion
weighted acquisitions, which were corrected for eddy current and mo-
tion artifacts and bad acquisitions were removed via the automatic DTI
quality control tool DTIPrep (Gilmore et al., 2007; Mullen, 1995) The
analysis is performed by registration of the Krabbe cases into a DTI
atlas built fromnormal neonate controls. In order to build the normative
DTI atlas, we used an unbiased diffeomorphic atlas building method
based on a non-linear ﬂuid deformation method (Wang Y Gupta
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ized FA is selected as the feature for atlas building (Mukherjee et al.,
2002). All the tensor images are reoriented into the unbiased space
using ﬁnite strain approximation. The atlas is then computed by averag-
ing all the reoriented tensor images in log-Euclidean space. Having
achieved an unbiased DTI atlas space, all tensor images were remapped
into this atlas using a full tensor registration method called DTI-ToolKit,
a non-parametric, diffeomorphic deformable image registration that
has shown superior performance in Krabbe neonates compared to
seven other non-linear registration methods (Wang et al., 2011). The
Krabbe cases were mapped into the atlas using that same registration
method to allow for direct comparison of DTI properties in the DTI
atlas space of Krabbe and control subjects. For the analysis, the ﬁber cir-
cuitries of interest were determined in collaboration with a neuroanat-
omist. The DTI properties along the ﬁber tracts were extracted for all
cases in their original DTI image space by inverse application of the
atlas registration deformation ﬁeld. Using a prior deﬁnition of a tract or-
igin plane in atlas space, which deﬁnes a curvilinear re-
parameterization of the tracts, corresponding average ﬁber bundle
property proﬁles of FA, AD, RD and MD are extracted from the ﬁber
tracts. Fig. 1 shows the details of DTI analysis.
An experienced neuroradiologist blinded to the DTI results scored
the MR images using the modiﬁed Loes score. For this, an experiencedFig. 1. Axial, coronal, and sagittal slices of the normal control diffusion tensor imaging atlas fro
regions of interest (genu, red; splenium, yellow; left and right internal capsule, celeste and sm
and Krabbe disease patient registered to the atlas (e, f, g).neuroradiologist blinded to the DTI results scored the MR images
using the modiﬁed Loes score.
2.5. Neurodevelopmental assessments
The Krabbe neonates underwent a detailed neurodevelopmental
evaluation within 2 days of the brain MRI and every 6–12 months. The
median follow-up time was 22.8 months with 4–10 follow-up evalua-
tions (median = 9). Cognitive, ﬁne and gross motor evaluations were
done using well-standardized and validated assessments for this age
population. These included the Peabody Developmental Motor Scales
(Folio and Fewell, 1983) (PDMS-2) and theMullen Scales of Early Learn-
ing (Mullen, 1995). Neonatal DTI measures were tested for their ability
to predict functional outcomes at their last follow-up evaluation.
2.6. Statistical analysis
To compare DTI results of Krabbe patients with control subjects, we
computed expected DTI value based on age at scanning, gestational age,
gender, and birthweight using a general linearmodel thatwasﬁt to 336
typically developing neonates. A ratio of observed to expected value
was calculated and converted to standard, normalized z-scores to create
the FA, MD, AD, and RD scores. To determine the relationship betweenm 336 controls (a, b, c). Three-dimensional visualization of target ﬁber tracts colored by
alt; left and right uncinate, peachblow and green) (d). Krabbe disease patient, the atlas,
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and gender), we used functional analysis of diffusion tensor tract statis-
tics (FADTTS), which provides a multivariate varying coefﬁcient model
to characterize relationships between ﬁber tract DTI properties and
the set of covariates (Zhu et al., 2011). The average value between the
groups for each tract was compared using general linear models.
Whitematter, graymatter, and CSF volumes of Krabbe patients and con-
trols were compared using model-estimated coefﬁcients. Functional
outcomemeasures at the last evaluation for each patient were convert-
ed to a functional ratio (calculated as age equivalence score divided by
chronologic age). Pearson correlationswere used to determinewhether
DTI results were associated with Loes scores or long-term functional
outcomes.
3. Results
3.1. DTI parameters
After adjusting for gestational age, birth weight, gender, and race
(Table 1), the Krabbe group had signiﬁcantly lower FA for all six tracts
compared with controls (p b 0.001) (Fig. 2), with no signiﬁcant differ-
ences in hemispheric asymmetry (Table 2). Similarly, MD and RD of
Krabbe patients were signiﬁcantly higher for all six tracts, and AD was
slightly higher for corticospinal internal capsule, right uncinate, and
genu. Fig. 3 shows the group coefﬁcient plots from the linear model ﬁt
of FADTTS data, illustrating the size and directionality of group differ-
ences along the ﬁber. Krabbe patients showed the following differences
when compared to controls: FA values were signiﬁcantly lower along
the length of the corticospinal and genu tracts of Krabbe patients.
Focal regional differences were detected in splenium and uncinate
fasciculus.MD and RDwere signiﬁcantly higher in the corticospinal, un-
cinate and genu tracts. ADwas slightly higher in the corticospinal tracts.
3.2. Correlation of DTI parameters with functional outcomes
There was a strong positive correlation of the neonatal FA score in
the corticospinal tracts of the six surviving patients with their long-
term neurodevelopmental function (cognitive, ﬁne motor, and gross
motor) (range 3–8 years post-transplant) (Table 3; Fig. 3). In contrast,
FA and AD in splenium and uncinate fasciculus only correlated strongly
with cognitive function. Of the two patients with the highest FA scores,
one is able towalk and run at 9 years of age, and the other canwalkwith
a walker at 48 months. The patient with the lowest neonatal FA score
shows the greatest motor delay and is not able to walk independently
at 25 months of age. Another patient with low FA is not able to walk
independently at 9 years and has the gross motor development of a
typical 10-month-old.Table 1
Demographics of transplanted Krabbe disease patients and normal controls.
Krabbe disease patients (n = 9)
Mean SD Min
Birth weight, g 3212.4 596.26 2280
Gestational age, weeks (weeks) 38.8 1.9 34.5
Age at MRI, weeks 15.3 8.3 7.0
Gender (% male) 56%
Race
Asian 0%
Black 0%
American Indian 0%
White 100%
Ethnicity
Hispanic 11%3.3. Volumetric differences between subject groups
Compared to controls, Krabbe patients showed slightly larger vol-
umes (10%–15%) of gray and white matter within frontal and parietal
regions, and 17% higher white matter volume in the right occipital re-
gion. The CSF volume was increased by 41% (Table 4). Examination of
the lateral ventricles revealed a laterality effect, with the left ventricle
showing greater enlargement than the right (83% vs. 22%).
3.4. Relationship between Loes scoring and DTI parameters
DTI scores did not correlatewith overall Loes scores (refer to Supple-
mentary material).
4. Discussion
Our studies show that in Krabbe patients the DTI parameters
(FA, MD, and RD) differed signiﬁcantly with those of age- and gender-
matched normal controls in the six ﬁber tracts assessed. In contrast,
AD values differed only in the corticospinal tracts. FA has the highest
correlation coefﬁcient with the myelin water fraction (Mädler et al.,
2008). The signiﬁcantly lower FA in the six ﬁber tracts of Krabbe pa-
tients compared to normal controls may be a strong indicator of poor
myelination. However, FA is also sensitive to non-myelin-related struc-
tural and biochemical changes. For example, in compact white matter
structures such as the genu of the corpus callosum, the highly organized
directionality of the ﬁber bundle would result in a higher FA value com-
pared with a less compact white matter structure. In addition to poor
myelination, disorganization of the ﬁber bundles may also be responsi-
ble for the lower FA values in Krabbe disease. Histological studies and
myelin-speciﬁc MRI sequences have demonstrated that myelination
begins in the cerebellum, pons and internal capsule, proceeding caudo-
cranially to the splenium of the corpus callosum and optic radiations, to
the occipital and parietal lobes, and ﬁnally to the genu of the corpus
callosum and frontal and temporal lobes. In neonates, this spatiotempo-
ral progression of myelination may affect DTI parameters along the dif-
ferent ﬁber tracts. Hence, in ﬁber tracts like the uncinate, lower FA
values could be attributed to the early stage of life when this tract is
less myelinated even in typically developing infants.
Krabbe patients showed higher values for RD, which is a speciﬁc
marker of demyelination and dysmyelination (Song et al., 2002). How-
ever, inﬂammation around the axons could also contribute to increased
RD. Interpretation of RD is difﬁcult because any process affecting ﬁber
diameter or membrane permeability could alter perpendicular diffusiv-
ity. In terms of AD, two processes have been shown to directly affect its
values: inﬂammation around the axonal structures with tissue swelling,
and axonopathy or axonal damage. Recent studies have reportedControls (n = 336)
Max Mean SD Min Max
4130 2773.6 742.0 790 4701
40.0 37.0 3.0 27.4 42.1
34.0 26.5 25.2 0 120.0
51%
2%
22%
1%
76%
15%
Fig. 2. Figure shows the ﬁber tract (colored by fractional anisotropy [FA] values) in the brain and on the FA scalar image (derived from diffusion tensor imaging), FA proﬁles along the length of
the tract of the Krabbe subjects with mean and standard deviation when compared to controls, and scatter plot of normalized FA values plotted against gestational age (in weeks) for the
corticospinal internal capsule (left), genu, splenium, and uncinate tracts (left). The yellow window in the FA tract proﬁle indicates values considered for statistical analysis.
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and inﬂammation around axonal structures with endoneural edema in
mouse models of Krabbe disease (Potter et al., 2013). In our studies,
AD for the corticospinal tracts, right uncinate, and genuwas signiﬁcant-
ly higher in Krabbe patients,whereas increases inAD in the left uncinate
and splenium tracts were not signiﬁcant. These differences in AD for
different tracts are assumed to be due to a combination of axonopathy,
a condition similar to disorganization, which lowers AD, and inﬂamma-
tion around axonal structures, which increases AD. The higher MD for
Krabbe disease patients can be attributed to demyelination and inﬂam-
mation of axons. Thus, a study of the four DTI parameters suggests
active demyelination, reduced myelination, and ongoing inﬂammation
in the brain of neonateswith Krabbe disease. Certainly, the above differ-
ences in all the four DTI parameters between the Krabbe and the normal
controls show the potential of using DTI as a biomarker for detecting
early changes in the brain before clinical symptoms develop. DTI couldTable 2
Differences in effect size of diffusion tensor imaging parameters between patients with Krabbe
FA MD
Diff SE p Diff SE p
L CSIC −2.63 0.34 b.001 2.31 0.34 b.
R CSIC −2.85 0.34 b.001 2.24 0.35 b.
L Unc −2.46 0.35 b.001 1.37 0.34 b.
R Unc −2.17 0.35 b.001 1.51 0.34 b.
Genu −2.15 0.34 b.001 1.51 0.34 b.
Splenium −1.67 0.35 b.001 0.69 0.34 0.
AD, axial diffusivity; CSIC, corticospinal internal capsule; Diff, difference; FA, fractional anisotroalso help predict timing of disease onset and expected phenotype in
babies who screen positive for Krabbe disease. Strong correlations be-
tween neonatal DTI metrics and functional outcomes indicate that DTI
can help determine the optimal time of treatment and predict functional
outcomes in the absence of transplant-related complications. Predicting
outcomeswith neonatal DTImeasures ismore objective, and themethod-
ology is easier to disseminate to sites that lack experience in evaluating
these patients.
In contrast to DTI ﬁndings, Loes scores do not correlate with func-
tional outcomes. The reason for thismay be that at term-age equivalent,
the neonatal brain is difﬁcult to assess because the cerebral white
matter is still not myelinated. The corresponding high T2 signal intesity
can be difﬁcult to distinguish from pathological signal intensity. In addi-
tion, qualitative assessment of volume loss and atrophy of neonatal ce-
rebral structures (including corpus callosum) can be inconsistent
among neuroradiologists. The difﬁculty involved in visual assessmentdisease (n= 9) and age- and gender-matched controls (n= 336).
RD AD
Diff SE p Diff SE p
001 2.54 0.34 b.001 1.57 0.35 b.001
001 2.55 0.35 b.001 1.32 0.35 0.002
001 1.74 0.34 b.001 0.54 0.34 0.115
001 1.77 0.34 b.001 0.86 0.34 0.012
001 1.81 0.34 b.001 0.71 0.34 0.036
041 0.99 0.34 0.004 0.09 0.34 0.798
py; L, left; MD, mean diffusivity; R, right; RD, radial diffusivity; Unc, uncinate.
Fig. 3. Plot showing correlation between the fractional anisotropy score (normalized mean ratio) within the internal capsule left tract and the gross motor and cognitive function scores.
Table 4
Age- and gender-adjusted mean brain volumes for Krabbe disease patients (n= 8) and
normal controls (n= 336).
Region Tissue Controls Patients Difference % p*
Mean SE Mean SE
Frontal Gray 70.6 0.48 77.8 3.65 7.2 10% 0.052
797A. Gupta et al. / NeuroImage: Clinical 7 (2015) 792–798and the inconsistency between neuroradiologists3 readings prompted
us to develop a consistent quantitative biomarker that is not subjective.
An interesting ﬁnding is that in addition to the white matter micro-
structural differences, Krabbe seems to have volumetric differences in
both gray and white matter, with surprisingly enlarged volumes in the
lateral ventricles and the total cerebrospinal ﬂuid. This could be the re-
sult of inﬂammation of the more central, early myelinating structures.
The left lateral ventricle was more enlarged than the right in Krabbe,
which may be due to differences in myelination rates of the left and
right periventricular areas in newborns. However, in newborns with
Krabbe disease the left periventricular area may have already under-
gone myelination and subsequent demyelination, resulting in atrophy
by the time the baby is born. Whether this is the reason for greater
enlargement of the left ventricle would be an interesting question to
address in future research.
One limitation of our study is the small number of infants with
Krabbe disease; however, this represents a large portion of this popula-
tion, and the results are statistically signiﬁcant. Although a random
sampling technique was not used, we used sequential enrollment
(i.e., each child diagnosed with early-infantile Krabbe disease who pre-
sented at our center underwent imaging). During the study period, our
center saw nearly all presymptomatic children in the United States
suspected of having early-infantile Krabbe disease; therefore, there isTable 3
Pearson correlations between neurodevelopment at the last follow-up evaluation and diffu-
sion tensor imaging parameters at baseline for the six surviving Krabbe disease patients.
DTI parameter Fiber tract Cog
(r)
AB
(r)
GM
(r)
FM
(r)
FA CSIC 0.96* 0.37 0.79 0.70
Genu 0.22 −0.61 −0.22 −0.36
Splenium 0.79 −0.06 0.45 0.32
Uncinate 0.84 0.03 0.53 0.40
MD CSIC −0.12 −0.09 0.01 0.12
Genu 0.30 0.46 0.55 0.65
Splenium −0.10 0.46 0.27 0.40
Uncinate 0.36 −0.28 0.23 0.25
RD CSIC −0.27 −0.14 −0.12 0.00
Genu 0.25 0.53 0.54 0.65
Splenium −0.46 0.29 −0.08 0.07
Uncinate 0.04 −0.23 0.05 0.13
AD CSIC 0.29 0.06 0.36 0.43
Genu 0.43 0.23 0.53 0.60
Splenium 0.97* 0.20 0.75 0.65
Uncinate 0.72 −0.26 0.42 0.35
AB, adaptive behavior; AD, axial diffusivity; Cog, cognitive function; CSIC, corticospinal
internal capsule; DTI, diffusion tensor imaging; FA, fractional anisotropy; FM, ﬁne motor
function; GM, gross motor function; MD, mean diffusivity; RD, radial diffusivity.
* p b .05.no reason to believe that these results would differ from those obtained
from a random sample.5. Conclusion
Differences observed in FA in the corticospinal tract differentiate be-
tween babies who will develop early-infantile disease from those with
later-onset disease. This DTI-based approach produces consistent re-
sults and detects small regional differences and age-related changes in
the neonatal period. For this reason, DTI with quantitative tractography
is an excellent technology for studying infantile Krabbe disease and can
be a key component of Krabbe newborn screening to help determine
which infants should receive treatment before symptoms develop.Right 37.8 0.26 41.6 1.95 3.7 10% 0.059
Left 32.7 0.23 36.2 1.76 3.4 11% 0.054
Frontal White 62.4 0.43 69.9 3.40 7.4 12% 0.031
Right 30.3 0.21 34.1 1.67 3.8 13% 0.024
Left 32.2 0.23 35.8 1.78 3.6 11% 0.045
Occipital Gray 68.6 0.51 72.0 3.84 3.4 5% 0.382
Right* 33.0 0.26 35.6 1.94 2.6 8% 0.183
Left* 35.6 0.27 36.4 1.99 0.8 2% 0.697
Occipital White 42.0 0.35 47.3 2.99 5.3 13% 0.082
Right* 19.6 0.17 23.0 1.47 3.4 17% 0.023
Left* 22.4 0.19 24.3 1.59 1.9 8% 0.242
Parietal Gray 60.1 0.40 69.1 3.25 9.0 15% 0.006
Right 31.0 0.21 34.9 1.67 3.9 13% 0.020
Left 29.1 0.21 34.2 1.65 5.1 18% 0.002
Parietal White 48.0 0.34 54.2 2.93 6.2 13% 0.036
Right 24.0 0.17 26.7 1.48 2.6 11% 0.078
Left 23.9 0.17 27.5 1.48 3.6 15% 0.017
Cerebellum Gray 22.8 0.15 23.4 1.17 0.5 2% 0.649
Cerebellum White 1.5 0.15 3.0 1.17 1.5 100% 0.198
Corpus callosum White 1.7 0.03 1.8 0.26 0.08 5% 0.752
Brainstem and
midbrain
White 3.8 0.08 4.2 0.76 0.4 10% 0.6265
Lateral ventricles
Right* 2.4 0.07 2.93 0.47 0.53 22% 0.267
Left* 2.25 0.07 4.12 0.44 1.87 83% b.001
Total
cerebrospinal
ﬂuid
52.7 0.56 74.3 5.33 21.6 41% b.001
* Signiﬁcant difference between group effects for the left versus right hemisphere
(p b 0.05).
798 A. Gupta et al. / NeuroImage: Clinical 7 (2015) 792–798This tool has the potential to have extended applications in predicting
motor and cognitive involvement in other leukodystrophies.
We have developed a quantitative DTI based tractography tool that
can be used for predicting functional outcomes in asymptomatic
neonates with Krabbe disease diagnosed because of family history or
newborn screening.
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